Actively Recruiting
Prospective 4D CTA of BAV Competence
Led by University of Pennsylvania · Updated on 2026-02-06
60
Participants Needed
1
Research Sites
369 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study involves annual 4D CTA imaging of the bicuspid aortic valve for a period of 5 years. CTA is often standard of care for BAV patients, but patients in this study will receive a higher radiation dose with a 4D imaging protocol. There may also be patients enrolled in the study who have a 4D CTA for research purposes when a routine CTA is not required for clinical care.
CONDITIONS
Official Title
Prospective 4D CTA of BAV Competence
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years of age
- Documented bicuspid aortic valve confirmed by clinical imaging with minimal calcification at enrollment
- Participant must sign the informed consent form
You will not qualify if you...
- Pregnancy confirmed by urine test
- Renal failure with estimated glomerular filtration rate below 30
- Known allergy to intravenous contrast unless steroid preparation is used as part of routine clinical care
- Previous aortic valve replacement
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here